Nicholas Battis, Samuel F Ekstein, Eric Eugene Paul Cosky, Anne B Neeley
{"title":"患者报告的 COVID-19 感染或疫苗接种与过敏性接触性皮炎发病之间的关联。","authors":"Nicholas Battis, Samuel F Ekstein, Eric Eugene Paul Cosky, Anne B Neeley","doi":"10.1089/derm.2023.0379","DOIUrl":null,"url":null,"abstract":"<p><p><u><b><i>Background:</i></b></u> Over the course of the COVID-19 pandemic, our clinic has encountered numerous patients who report that either COVID-19 vaccination or infection was the precipitating event for their development of allergic contact Dermatitis® (ACD). Up to this time, there is no formal investigation regarding COVID-19 vaccination or infection causing ACD. However, there have been several registry-based case series of associated dermatoses after COVID-19 infection or vaccination. <u><b><i>Objective:</i></b></u> This study aimed to describe patient-reported associations between COVID-19 infection or vaccination and onset of ACD. <u><b><i>Methods:</i></b></u> A single-center retrospective noncomparative chart review of 1073 patients patch tested at the Park Nicollet Contact Dermatitis® Clinic (Minneapolis, MN) from March 1, 2020, to March 1, 2022, was performed. <u><b><i>Results:</i></b></u> Of 1073 patients included in our study, 5 patients (0.47%) reported ACD symptom onset after COVID-19 infection and 12 patients (1.11%) reported onset after COVID-19 vaccination. Rates of clinical relevance were not significantly different than the general population for those who attributed ACD to COVID-19 infection or vaccination. <u><b><i>Conclusions:</i></b></u> To our knowledge, this is the first study in the literature investigating the potential association between COVID-19 vaccination or infection and the development of ACD through extensive retrospective chart review.</p>","PeriodicalId":93974,"journal":{"name":"Dermatitis : contact, atopic, occupational, drug","volume":" ","pages":"614-617"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Patient-Reported Association Between COVID-19 Infection or Vaccination and Onset of Allergic Contact Dermatitis®.\",\"authors\":\"Nicholas Battis, Samuel F Ekstein, Eric Eugene Paul Cosky, Anne B Neeley\",\"doi\":\"10.1089/derm.2023.0379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><u><b><i>Background:</i></b></u> Over the course of the COVID-19 pandemic, our clinic has encountered numerous patients who report that either COVID-19 vaccination or infection was the precipitating event for their development of allergic contact Dermatitis® (ACD). Up to this time, there is no formal investigation regarding COVID-19 vaccination or infection causing ACD. However, there have been several registry-based case series of associated dermatoses after COVID-19 infection or vaccination. <u><b><i>Objective:</i></b></u> This study aimed to describe patient-reported associations between COVID-19 infection or vaccination and onset of ACD. <u><b><i>Methods:</i></b></u> A single-center retrospective noncomparative chart review of 1073 patients patch tested at the Park Nicollet Contact Dermatitis® Clinic (Minneapolis, MN) from March 1, 2020, to March 1, 2022, was performed. <u><b><i>Results:</i></b></u> Of 1073 patients included in our study, 5 patients (0.47%) reported ACD symptom onset after COVID-19 infection and 12 patients (1.11%) reported onset after COVID-19 vaccination. Rates of clinical relevance were not significantly different than the general population for those who attributed ACD to COVID-19 infection or vaccination. <u><b><i>Conclusions:</i></b></u> To our knowledge, this is the first study in the literature investigating the potential association between COVID-19 vaccination or infection and the development of ACD through extensive retrospective chart review.</p>\",\"PeriodicalId\":93974,\"journal\":{\"name\":\"Dermatitis : contact, atopic, occupational, drug\",\"volume\":\" \",\"pages\":\"614-617\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatitis : contact, atopic, occupational, drug\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/derm.2023.0379\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatitis : contact, atopic, occupational, drug","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/derm.2023.0379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Patient-Reported Association Between COVID-19 Infection or Vaccination and Onset of Allergic Contact Dermatitis®.
Background: Over the course of the COVID-19 pandemic, our clinic has encountered numerous patients who report that either COVID-19 vaccination or infection was the precipitating event for their development of allergic contact Dermatitis® (ACD). Up to this time, there is no formal investigation regarding COVID-19 vaccination or infection causing ACD. However, there have been several registry-based case series of associated dermatoses after COVID-19 infection or vaccination. Objective: This study aimed to describe patient-reported associations between COVID-19 infection or vaccination and onset of ACD. Methods: A single-center retrospective noncomparative chart review of 1073 patients patch tested at the Park Nicollet Contact Dermatitis® Clinic (Minneapolis, MN) from March 1, 2020, to March 1, 2022, was performed. Results: Of 1073 patients included in our study, 5 patients (0.47%) reported ACD symptom onset after COVID-19 infection and 12 patients (1.11%) reported onset after COVID-19 vaccination. Rates of clinical relevance were not significantly different than the general population for those who attributed ACD to COVID-19 infection or vaccination. Conclusions: To our knowledge, this is the first study in the literature investigating the potential association between COVID-19 vaccination or infection and the development of ACD through extensive retrospective chart review.